TERESA FERNÁNDEZ-ACERO BASCONES

Dr. TERESA FERNÁNDEZ-ACERO BASCONES


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 April 2022 in Journal of Fungi
Verified
Journal Article
Open access
PDF file
GRGema González Rubio
Gema González Rubio
LSLucía Sastre-Vergara
Lucía Sastre-Vergara
MMMaría Molina Martín
María Molina Martín
Humberto MartínHumberto Martín
Humberto Martín
TBTERESA FERNÁNDEZ-ACERO BASCONES
TERESA FERNÁNDEZ-ACERO BASCONES
The cell wall integrity (CWI) MAPK pathway of budding yeast Saccharomyces cerevisiae is specialized in responding to cell wall damage, but ongoing research shows that it participates in many other stressful conditions, suggesting that it has functional diversity. The output of this pathway is mainly driven by the activity of the MAPK Slt2, which regulates important processes for yeast physiology such as fine-tuning of signaling through the CWI and other pathways, transcriptional activation in response to cell wall damage, cell cycle, or determination of the fate of some organelles. To this end, Slt2 precisely phosphorylates protein substrates, modulating their activity, stability, protein interaction, and subcellular localization. Here, after recapitulating the methods that have been employed in the discovery of proteins phosphorylated by Slt2, we review the bona fide substrates of this MAPK and the growing set of candidates still to be confirmed. In the context of the complexity of MAPK signaling regulation, we discuss how Slt2 determines yeast cell integrity through phosphorylation of these substrates. Increasing data from large-scale analyses and the available methodological approaches pave the road to early identification of new Slt2 substrates and functions.

4 April 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
ÓBÓscar Barbero-Úriz
Óscar Barbero-Úriz
MVMarta Valenti Valenti
Marta Valenti Valenti
MMMaría Molina Martín
María Molina Martín
TBTERESA FERNÁNDEZ-ACERO BASCONES
TERESA FERNÁNDEZ-ACERO BASCONES
VCVictor Cid
Victor Cid
The yeast Saccharomyces cerevisiae is the paradigm of a eukaryotic model organism. In virtue of a substantial degree of functional conservation, it has been extensively exploited to understand multiple aspects of the genetic, molecular, and cellular biology of human disease. Many aspects of cell signaling in cancer, aging, or metabolic diseases have been tackled in yeast. Here, we review the strategies undertaken throughout the years for the development of humanized yeast models to study regulated cell death (RCD) pathways in general, and specifically, those related to innate immunity and inflammation, with an emphasis on pyroptosis and necroptosis. Such pathways involve the assembly of distinct modular signaling complexes such as the inflammasome and the necrosome. Like other supramolecular organizing centers (SMOCs), such intricate molecular arrangements trigger the activity of enzymes, like caspases or protein kinases, culminating in the activation of lytic pore-forming final effectors, respectively, Gasdermin D (GSDMD) in pyroptosis and MLKL in necroptosis. Even though pathways related to those governing innate immunity and inflammation in mammals are missing in fungi, the heterologous expression of their components in the S. cerevisiae model provides a “cellular test tube” to readily study their properties and interactions, thus constituting a valuable tool for finding novel therapies.

12 March 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ÓBÓscar Barbero-Úriz
Óscar Barbero-Úriz
MVMarta Valenti Valenti
Marta Valenti Valenti
MMMaría Molina Martín
María Molina Martín
TBTERESA FERNÁNDEZ-ACERO BASCONES
TERESA FERNÁNDEZ-ACERO BASCONES
VCVíctor J. Cid
Víctor J. Cid
The yeast Saccharomyces cerevisiae is the paradigm of a eukaryotic model organism. In virtue of a substantial degree of functional conservation, it has been extensively exploited to understand multiple aspects of the genetics, molecular and cellular biology of human disease. Many aspects of cell signaling in cancer, aging or metabolic diseases, have been tackled in yeast. Here, we review the strategies undertaken through the years for the development of humanized yeast models to study regulated cell death (RCD) pathways in general, and specifically those related to innate immunity and inflammation, with emphasis in pyroptosis and necroptosis. Such pathways involve the assembly of distinct modular signaling complexes such as the inflammasome and the necrosome. Like other supramolecular organizing centers (SMOCs), such intricate molecular arrangements trigger the activity of enzymes, like caspases or protein kinases, culminating in the activation of lytic pore-forming final effectors, respectively gasdermin D (GSDMD) in pyroptosis and MLKL in necroptosis. Even though pathways related to those governing innate immunity and inflammation in mammals are missing in fungi, heterologous expression of their components in the S. cerevisiae model provides a “cellular test tube” to readily study their properties and interactions, thus constituting a valuable tool for finding novel therapies.